Implantable cardioverter defibrillator with and without defibrillation threshold testing

Israel Medical Association Journal

Volumn 14, Issue 6, 2012, Pages 343-346

  Codner, Pablo ^a   Nevzorov, Roman ^a   Kusniec, Jairo ^a   Haim, Moti ^a   Zabarski, Ronit ^a   Strasberg, Boris ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti tachycardia pacing (ATP); Defibrillation threshold (DFT); Implantable cardioverter defibrillator (ICD); Sudden death; Ventricular fibrillation (VF); Ventricular tachycardia (VT)

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; COHORT ANALYSIS; COMPARATIVE STUDY; DEFIBRILLATION; DEFIBRILLATION THRESHOLD TESTING; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART DEATH; HEART PACING; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MATERIALS TESTING; MORTALITY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; TACHYCARDIA;

AGED; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; DIFFERENTIAL THRESHOLD; EQUIPMENT SAFETY; FEMALE; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSORY THRESHOLDS; UNNECESSARY PROCEDURES; VENTRICULAR FIBRILLATION;

EID: 84863335209     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-83.
2. Lee DS, Green LD, Liu PP, et al. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J Am Coll Cardiol 2003; 41: 1573-82.
3. Echt DS, Armstrong K, Schmidt P, Oyer PE, Stinson EB, Winkle RA. Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation 1985; 71: 289-96.
4. Day JD, Olshansky B, Moore S, Brown S, Stolen KQ, Lerew DR. High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems. Europace 2008; 10: 347-50.
5. Gold MR, Higgins S, Klein R, et al. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the low energy safety study (LESS). Circulation 2002; 105: 2043-8.
6. Lever NA, Newall EG, Larsen PD. Differences in the characteristics of induced and spontaneous episodes of ventricular fibrillation. Europace 2007; 9: 1054-8.
7. Viskin S, Rosso R. The top 10 reasons to avoid defibrillation threshold testing during ICD implantation. Heart Rhythm 2008; 5: 391-3.
8. Mainigi SK, Cooper JM, Russo AM, et al. Elevated defibrillation thresholds in patients undergoing biventricular defibrillator implantation: incidence and predictors. Heart Rhythm 2006; 3: 1010-16.
9. Curtis AB. Defibrillation threshold testing in implantable cardioverterdefibrillators: might less be more than enough. J Am Coll Cardiol 2008; 52: 557-8.
10. Birnie D, Tung S, Simpson C, et al. Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm 2008; 5: 387-90.
11. Brignole M, Raciti G, Bongiorni MG, et al. Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice: a nation-wide survey. Europace 2007; 9: 540-3.
12. Tokano T, Bach D, Chang J, et al. Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol 1998; 9: 791-7.
13. Runsiö M, Kallner A, Källner G, et al. Myocardial injury after electrical therapy for cardiac arrhythmias assessed by troponin-T release. Am J Cardiol 1997; 79: 1241-5.
14. Stix G, Hirschl M, Vukovich T, et al. Myocardial cell damage after repeated ICD therapies demonstrated by circulating cardiac specific proteins. PACE 1998; 21: 910.
15. Blatt JA, Poole JE, Johnson GW, et al. for the SCD-HeFT Investigators. No benefit from defibrillation threshold testing in the Sudden Cardiac Death in Heart Failure Trial. J Am Coll Cardiol 2008; 52: 551-6.
16. Bianchi S, Ricci RP, Biscione F, et al. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up. PACE 2009; 32: 573-8.
17. Calvi V, Dugo D, Capodanno D, et al. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it? Am Heart J 2010; 159: 98-102.
18. Strickberger SA, Klein GJ. Is defibrillation testing required for defibrillator implantation? J Am Coll Cardiol 2004; 44: 88-91.
19. Val-Mejias JE, Oza A. Does defibrillation threshold increase as left ventricular ejection fraction decreases? Europace 2010; 12: 385-8.
20. Hohnloser SH, Dorian P, Roberts R, et al. Effect of amiodarone and sotalol on ventricular defibrillation threshold. The optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. Circulation 2006; 114: 104-9.
21. Schuger C, Ellenbogen K, Faddis M, Knight BP, Young P, Sample R; VENTAK CHF/CONTAK CD Study Investigators. Defibrillation energy requirements in an ICD population receiving cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006; 17: 247-50.
22. Russo AM, Sauer W, Gerstenfeld EP, et al. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm 2005; 2: 456-61.
23. Gold MR, Higgins S, Klein R, et al. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the low energy safety study (LESS). Circulation 2002; 105: 2043-8.
24. Kolb C, Tzeis S, Zrenner B. Defibrillation threshold testing: tradition or necessity? PACE 2009; 32: 570-2.